NovoLabs

NovoLabs

Private
Palmerston NorthFrontier & Industrial Techhttps://novolabs.co.nz

Last Round

Debt

Jun 19, 2025

Est. Valuation

$8.65M

Total Funding Raised

$605,000

Momentum Score

50 /100

Company Overview

NovoLabs is a commercial products company that manufactures a patented Supercritical UV™ disinfection system for the effective treatment of process liquids and wastewaters.

Sector

Frontier & Industrial Tech

Verticals

Water Treatment, Clean Manufacturing, Waste Management

Business Model

B2G

Customer Profile

Hardware Sales, Government Contracts, Services & Consulting

AI Layer

Non-AI

Keywords

Supercritical UVwater disinfectionwastewater treatmentUV disinfectionlow-clarity water treatmentwater treatment hardwarechemical-free treatmentindustrial wastewatermunicipal wastewaterwater techcleantechturbid water treatmentpathogen reductionenvironmental compliancefood processing wastewateragricultural water treatment

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

NovoLabs Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

NovoLabs Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
DebtJun 19, 2025
Series AFeb 5, 2024

Key People

Founding team and executive leadership

Matthew Sells

Chief Executive Officer

Executive Team

Andy Shilton

Director And Chief Technology Officer

Executive Team

NovoLabs Investors

Notable investors and investment history

NovoLabs Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

NovoLabs Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about NovoLabs's valuation, stock price, and market status.

Firmographic Details

HeadquartersPalmerston North
Employee Range11
Year Founded2017
Last FundingJun 19, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.